CompletedNot Applicable

Motivational Interviewing (MI) Intervention to Improve Adherence

United States727 participantsStarted 2019-05-29

Plain-language summary

The purpose of this study is to examine the effectiveness of a telephone motivational interviewing intervention by pharmacy students in enhancing adherence to angiotensin converting enzyme inhibitors (ACEI)/ angiotensin receptor blockers (ARB) (ACE/ARBs) among patients with diabetes and hypertension in a Medicare advantage plan.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Continuous enrollment over the study period July 2016 to December 2018.
✓. A prescription filled for an ACEI or ARB medication between July 1st, 2017- December 31st, 2017. This will be defined as the index date (for phase 1).
✓. Diagnosis of both DM and HTN prior to index date, identified through the health plan's medical claims program (CCMS) using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes only.

Exclusion criteria

✕. Disenrollment from drug plan.
✕. Death prior to end of the study.
✕. Having a diagnosis of dementia in the one-year pre-index period.
✕. Having an ACEI/ARB contraindication like angioedema, hyperkalemia, and renal artery stenosis in the one-year pre-index period.

What they're measuring

Adherence Measure

Timeframe: 12 months following initial call

Trial details

NCT IDNCT03985098

SponsorUniversity of Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-22

Results submitted2023-01-31

View on ClinicalTrials.gov More Diabetes Mellitus, Type 2 trials